148 related articles for article (PubMed ID: 38431216)
1. Antibiotic-induced intestinal microbiota depletion can attenuate the acute kidney injury to chronic kidney disease transition via NADPH oxidase 2 and trimethylamine-N-oxide inhibition.
Lee J; Lee J; Kim K; Lee J; Jung Y; Hyeon JS; Seo A; Jin W; Weon B; Shin N; Kim S; Lim CS; Kim YS; Lee JP; Hwang GS; Yang SH
Kidney Int; 2024 Jun; 105(6):1239-1253. PubMed ID: 38431216
[TBL] [Abstract][Full Text] [Related]
2. Gut microbial metabolite TMAO contributes to renal dysfunction in a mouse model of diet-induced obesity.
Sun G; Yin Z; Liu N; Bian X; Yu R; Su X; Zhang B; Wang Y
Biochem Biophys Res Commun; 2017 Nov; 493(2):964-970. PubMed ID: 28942145
[TBL] [Abstract][Full Text] [Related]
3. Targeted Inhibition of Gut Microbial Trimethylamine N-Oxide Production Reduces Renal Tubulointerstitial Fibrosis and Functional Impairment in a Murine Model of Chronic Kidney Disease.
Gupta N; Buffa JA; Roberts AB; Sangwan N; Skye SM; Li L; Ho KJ; Varga J; DiDonato JA; Tang WHW; Hazen SL
Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1239-1255. PubMed ID: 32212854
[TBL] [Abstract][Full Text] [Related]
4. Xanthine oxidase/NADPH oxidase inhibition by hydralazine attenuates acute kidney injury and prevents the transition of acute kidney injury to chronic kidney disease.
Chiang CH; Chen C; Fang SY; Lin SC; Chen JW; Chang TT
Life Sci; 2023 Aug; 327():121863. PubMed ID: 37331504
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.
Tang WH; Wang Z; Kennedy DJ; Wu Y; Buffa JA; Agatisa-Boyle B; Li XS; Levison BS; Hazen SL
Circ Res; 2015 Jan; 116(3):448-55. PubMed ID: 25599331
[TBL] [Abstract][Full Text] [Related]
6. A short treatment with resveratrol after a renal ischaemia-reperfusion injury prevents maladaptive repair and long-term chronic kidney disease in rats.
Martínez-Rojas MÁ; Balcázar H; Ponce-Nava MS; González-Soria I; Marquina-Castillo B; Pérez-Villalva R; Bobadilla NA
J Physiol; 2024 Apr; 602(8):1835-1852. PubMed ID: 38529522
[TBL] [Abstract][Full Text] [Related]
7. Blockade of STAT3 signaling alleviates the progression of acute kidney injury to chronic kidney disease through antiapoptosis.
Park JY; Yoo KD; Bae E; Kim KH; Lee JW; Shin SJ; Lee JS; Kim YS; Yang SH
Am J Physiol Renal Physiol; 2022 May; 322(5):F553-F572. PubMed ID: 35311382
[TBL] [Abstract][Full Text] [Related]
8. Recombinant Long-Acting Thioredoxin Ameliorates AKI to CKD Transition via Modulating Renal Oxidative Stress and Inflammation.
Nishida K; Watanabe H; Murata R; Tokumaru K; Fujimura R; Oshiro S; Nagasaki T; Miyahisa M; Hiramoto Y; Nosaki H; Imafuku T; Maeda H; Fukagawa M; Maruyama T
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070521
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice.
Zhang W; Miikeda A; Zuckerman J; Jia X; Charugundla S; Zhou Z; Kaczor-Urbanowicz KE; Magyar C; Guo F; Wang Z; Pellegrini M; Hazen SL; Nicholas SB; Lusis AJ; Shih DM
Sci Rep; 2021 Jan; 11(1):518. PubMed ID: 33436815
[TBL] [Abstract][Full Text] [Related]
10. The interplay between microbiota-dependent metabolite trimethylamine N-oxide, Transforming growth factor β/SMAD signaling and inflammasome activation in chronic kidney disease patients: A new mechanistic perspective.
El-Deeb OS; Atef MM; Hafez YM
J Cell Biochem; 2019 Sep; 120(9):14476-14485. PubMed ID: 31002427
[TBL] [Abstract][Full Text] [Related]
11. Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients.
Xu KY; Xia GH; Lu JQ; Chen MX; Zhen X; Wang S; You C; Nie J; Zhou HW; Yin J
Sci Rep; 2017 May; 7(1):1445. PubMed ID: 28469156
[TBL] [Abstract][Full Text] [Related]
12. NFAT inhibitor 11R-VIVIT ameliorates mouse renal fibrosis after ischemia-reperfusion-induced acute kidney injury.
Xie ZY; Dong W; Zhang L; Wang MJ; Xiao ZM; Zhang YH; Shi WX; Huang Y; Yang Y; Li CL; Fu L; Zhao XC; Li RZ; Li ZL; Chen YH; Ye ZM; Liu SX; Dong Z; Liang XL
Acta Pharmacol Sin; 2022 Aug; 43(8):2081-2093. PubMed ID: 34937917
[TBL] [Abstract][Full Text] [Related]
13. Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2 axis.
Chen DQ; Feng YL; Chen L; Liu JR; Wang M; Vaziri ND; Zhao YY
Free Radic Biol Med; 2019 Apr; 134():484-497. PubMed ID: 30716432
[TBL] [Abstract][Full Text] [Related]
14. A two-stage bilateral ischemia-reperfusion injury-induced AKI to CKD transition model in mice.
Zhang J; Wang X; Wei J; Wang L; Jiang S; Xu L; Qu L; Yang K; Fu L; Buggs J; Cheng F; Liu R
Am J Physiol Renal Physiol; 2020 Aug; 319(2):F304-F311. PubMed ID: 32567350
[TBL] [Abstract][Full Text] [Related]
15. Tubular Epithelial Cell HMGB1 Promotes AKI-CKD Transition by Sensitizing Cycling Tubular Cells to Oxidative Stress: A Rationale for Targeting HMGB1 during AKI Recovery.
Zhao ZB; Marschner JA; Iwakura T; Li C; Motrapu M; Kuang M; Popper B; Linkermann A; Klocke J; Enghard P; Muto Y; Humphreys BD; Harris HE; Romagnani P; Anders HJ
J Am Soc Nephrol; 2023 Mar; 34(3):394-411. PubMed ID: 36857499
[TBL] [Abstract][Full Text] [Related]
16. Tubulovascular protection from protease-activated receptor-1 depletion during AKI-to-CKD transition.
Lok SWY; Yiu WH; Zou Y; Xue R; Li H; Ma J; Chen J; Chan LYY; Lai KN; Tang SCW
Nephrol Dial Transplant; 2023 Sep; 38(10):2232-2247. PubMed ID: 36914214
[TBL] [Abstract][Full Text] [Related]
17. Gut-Derived Trimethylamine N-Oxide Promotes CCR2-Mediated Macrophage Infiltration in acute kidney injury.
Ren Y; Wang Z; You L; Zhou J; Huang H; Chang S; Wu Y; Xue J
Nephrol Dial Transplant; 2024 Apr; ():. PubMed ID: 38587855
[TBL] [Abstract][Full Text] [Related]
18. Akt1 is involved in renal fibrosis and tubular apoptosis in a murine model of acute kidney injury-to-chronic kidney disease transition.
Kim IY; Song SH; Seong EY; Lee DW; Bae SS; Lee SB
Exp Cell Res; 2023 Mar; 424(2):113509. PubMed ID: 36773738
[TBL] [Abstract][Full Text] [Related]
19. Differential role of nicotinamide adenine dinucleotide deficiency in acute and chronic kidney disease.
Faivre A; Katsyuba E; Verissimo T; Lindenmeyer M; Rajaram RD; Naesens M; Heckenmeyer C; Mottis A; Feraille E; Cippà P; Cohen C; Longchamp A; Allagnat F; Rutkowski JM; Legouis D; Auwerx J; de Seigneux S
Nephrol Dial Transplant; 2021 Jan; 36(1):60-68. PubMed ID: 33099633
[TBL] [Abstract][Full Text] [Related]
20. The guanylate cyclase C agonist linaclotide ameliorates the gut-cardio-renal axis in an adenine-induced mouse model of chronic kidney disease.
Nanto-Hara F; Kanemitsu Y; Fukuda S; Kikuchi K; Asaji K; Saigusa D; Iwasaki T; Ho HJ; Mishima E; Suzuki T; Suzuki C; Tsukimi T; Matsuhashi T; Oikawa Y; Akiyama Y; Kure S; Owada Y; Tomioka Y; Soga T; Ito S; Abe T
Nephrol Dial Transplant; 2020 Feb; 35(2):250-264. PubMed ID: 31411705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
